These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11897408)

  • 1. Synthesis and evaluation of new oxamniquine derivatives.
    Filho SB; Gargioni C; Silva Pinto PL; Chiodelli SG; Gurgel Vellosa SA; da Silva RM; da Silveira MA
    Int J Pharm; 2002 Feb; 233(1-2):35-41. PubMed ID: 11897408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and in vivo evaluation of oxamniquine methacrylate and acrylamide prodrugs.
    Filho RP; de Souza Menezes CM; Pinto PL; Paula GA; Brandt CA; da Silveira MA
    Bioorg Med Chem; 2007 Feb; 15(3):1229-36. PubMed ID: 17134907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on some derivatives of oxamniquine.
    el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
    J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Schistosoma mansoni isolates from patients with failure of treatment with oxamniquine.
    Conceição MJ; Argento CA; Corrêa A
    Mem Inst Oswaldo Cruz; 2000; 95(3):375-80. PubMed ID: 10800196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the increase of portal pressure during the acute and chronic phases of murine schistosomiasis mansoni and its reversibility after treatment with oxamniquine.
    Costa G; Aguiar BG; Coelho PM; Cunha-Melo JR
    Acta Trop; 2003 Dec; 89(1):13-6. PubMed ID: 14636977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
    Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
    [No Abstract]   [Full Text] [Related]  

  • 9. Preliminary investigations of some derivatives of oxamniquine.
    Karekezi CW; Lucas PD; Marples BA; Salt WG
    J Chemother; 1995 Apr; 7(2):133-5. PubMed ID: 7666119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.
    Stelma FF; Sall S; Daff B; Sow S; Niang M; Gryseels B
    J Infect Dis; 1997 Jul; 176(1):304-7. PubMed ID: 9207389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for treating schistosomiasis mansoni.
    Saconato H; Atallah A
    Cochrane Database Syst Rev; 2000; (2):CD000528. PubMed ID: 10796552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of schistosomiasis: gathering stones together.
    Lambertucci JR
    Mem Inst Oswaldo Cruz; 1995; 90(2):161-4. PubMed ID: 8531651
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatic regeneration after partial hepatectomy in mice infected with Schistosoma mansoni, at the acute and chronic phases of the disease.
    Costa G; Cunha-Melo JR; Aguiar BG; Gonçalves SC; Toppa NH; Coelho PM
    Rev Inst Med Trop Sao Paulo; 1999; 41(4):255-8. PubMed ID: 10564921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of specific treatment on the morbidity of Schistosomiasis mansoni in an endemic area of Minas Gerais, Brazil.
    Conceicao MJ; Borges-Pereira J
    Mem Inst Oswaldo Cruz; 2002 Jul; 97(5):755-7. PubMed ID: 12219148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replacing oxamniquine by praziquantel against Schistosoma mansoni infection in a rural community from the sugar-cane zone of Northeast Brazil: an epidemiological follow-up.
    Beck L; Favre TC; Pieri OS; Zani LC; Domas GG; Barbosa CS
    Mem Inst Oswaldo Cruz; 2001; 96 Suppl():165-7. PubMed ID: 11586444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case 4-1996: paralysis due to schistosomiasis.
    Cook J; Reich MR
    N Engl J Med; 1996 Jun; 334(23):1548; author reply 1548-9. PubMed ID: 8618622
    [No Abstract]   [Full Text] [Related]  

  • 18. The association of steroids and schistosomicides in the treatment of experimental schistosomiasis.
    Lambertucci JR; Modha J; Curtis R; Doenhoff M
    Trans R Soc Trop Med Hyg; 1989; 83(3):354-7. PubMed ID: 2515622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
    Coelho PM; Lima e Silva FC; Nogueira-Machado JA
    Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schistosoma mansoni: permanence of modulation of the granulomatous inflammatory response in mice cured in the chronic phase.
    Coelho PM; Toppa NH; Feldmann JS; Gonçalves R; Mello RT
    Int J Parasitol; 1996 Dec; 26(12):1393-5. PubMed ID: 9024890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.